Orthofix beats The Street in Q2, upping full-year guidance

Orthofix Medical

(NASDAQ:OFIX)
+
 posted second-quarter results this evening that beat the consensus forecast on Wall Street.
It also raised its revenue and adjusted EBITDA guidance for the rest of the year, reflecting positive developments in Bone…

Source: www.massdevice.com – Read more